Abbott Confirms Unauthorized Access to Cancer Diagnostics Systems

Abbott Laboratories disclosed a cybersecurity incident involving unauthorized access to a limited set of internal systems within its Cancer Diagnostics division; the company says the intrusion is contained to that business unit, has not affected broader operations or manufacturing, and legacy Exact Sciences systems remain unaffected. Abbott has engaged third-party forensic specialists and law enforcement to determine the scope and nature of the access, and has not yet confirmed whether patient data, diagnostic records, or proprietary information were compromised.